Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Martin Metz

Showing results (211-220 of 258) with videos related to

Pageof 26
Sort By:
Allergy|December 10, 2019
Development of the Angioedema Control Test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedemaKarsten Weller, Tamara Donoso, Markus Magerl, et al.
Immunotherapy|March 31, 2025
Benralizumab for the treatment of chronic spontaneous urticaria: a plain language summary of the ARROYO studySabine Altrichter, Ana Maria Giménez-Arnau, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 17, 2020
Validation of the Angioedema Control Test (AECT)-A Patient-Reported Outcome Instrument for Assessing Angioedema ControlKarsten Weller, Tamara Donoso, Markus Magerl, et al.
Nature Reviews. Drug Discovery|August 1, 2023
Type 2 chronic inflammatory diseases: targets, therapies and unmet needsPavel Kolkhir, Cezmi A Akdis, Mübeccel Akdis, et al.
Neurobiology of Disease|October 1, 2013
Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4Sofie Nelissen, Tim Vangansewinkel, Nathalie Geurts, et al.
Allergy|August 19, 2023
Efficacy and safety of on-demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trialKarsten Weller, Ana Maria Gimenez-Arnau, Jens Baron, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 15, 2026
Remibrutinib impact on disease control, sleep, and quality of life: Analysis of phase 3 REMIX-1/2Giselle Mosnaim, Sarbjit Saini, Mark Lebwohl, et al.
The New England Journal of Medicine|March 5, 2025
Remibrutinib in Chronic Spontaneous UrticariaMartin Metz, Ana Giménez-Arnau, Michihiro Hide, et al.
Clinical and Translational Allergy|October 25, 2023
Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi surveyKaroline Krause, Hanna Bonnekoh, Jannis Jelden-Thurm, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 22, 2026
Global Real-World Validation of First-Day Urticaria Activity Score (UAS1)Lanka Huidong Su, Bernardo Sousa Pinto, Aiste Ramanauskaite, et al.
Pageof 26

Showing results (211-220 of 258) with videos related to

Sort By:
Pageof 26
Allergy|December 10, 2019
Development of the Angioedema Control Test-A patient-reported outcome measure that assesses disease control in patients with recurrent angioedemaKarsten Weller, Tamara Donoso, Markus Magerl, et al.
Immunotherapy|March 31, 2025
Benralizumab for the treatment of chronic spontaneous urticaria: a plain language summary of the ARROYO studySabine Altrichter, Ana Maria Giménez-Arnau, Jonathan A Bernstein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|March 17, 2020
Validation of the Angioedema Control Test (AECT)-A Patient-Reported Outcome Instrument for Assessing Angioedema ControlKarsten Weller, Tamara Donoso, Markus Magerl, et al.
Nature Reviews. Drug Discovery|August 1, 2023
Type 2 chronic inflammatory diseases: targets, therapies and unmet needsPavel Kolkhir, Cezmi A Akdis, Mübeccel Akdis, et al.
Neurobiology of Disease|October 1, 2013
Mast cells protect from post-traumatic spinal cord damage in mice by degrading inflammation-associated cytokines via mouse mast cell protease 4Sofie Nelissen, Tim Vangansewinkel, Nathalie Geurts, et al.
Allergy|August 19, 2023
Efficacy and safety of on-demand versus daily rupatadine in chronic spontaneous urticaria: A randomized trialKarsten Weller, Ana Maria Gimenez-Arnau, Jens Baron, et al.
Annals of Allergy, Asthma & Immunology : Official Publication of the American College of Allergy, Asthma, & Immunology|June 15, 2026
Remibrutinib impact on disease control, sleep, and quality of life: Analysis of phase 3 REMIX-1/2Giselle Mosnaim, Sarbjit Saini, Mark Lebwohl, et al.
The New England Journal of Medicine|March 5, 2025
Remibrutinib in Chronic Spontaneous UrticariaMartin Metz, Ana Giménez-Arnau, Michihiro Hide, et al.
Clinical and Translational Allergy|October 25, 2023
Differential diagnosis between urticarial vasculitis and chronic spontaneous urticaria: An international Delphi surveyKaroline Krause, Hanna Bonnekoh, Jannis Jelden-Thurm, et al.
The Journal of Allergy and Clinical Immunology. in Practice|April 22, 2026
Global Real-World Validation of First-Day Urticaria Activity Score (UAS1)Lanka Huidong Su, Bernardo Sousa Pinto, Aiste Ramanauskaite, et al.
Pageof 26